vs
OLAPLEX HOLDINGS, INC.（OLPX）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
再鼎医药的季度营收约是OLAPLEX HOLDINGS, INC.的1.2倍（$127.1M vs $105.1M），再鼎医药同比增速更快（17.1% vs 4.3%），OLAPLEX HOLDINGS, INC.自由现金流更多（$32.6M vs $-26.7M），过去两年再鼎医药的营收复合增速更高（20.8% vs 3.1%）
Olaplex Holdings是一家专业美容企业，主打专利头发键结构修复护发产品，运营沙龙专业分销、直面消费者销售、第三方零售三大核心板块，产品可修复烫染、高温等导致的发质损伤，销售网络覆盖北美、欧洲及亚太地区。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
OLPX vs ZLAB — 直观对比
营收规模更大
ZLAB
是对方的1.2倍
$105.1M
营收增速更快
ZLAB
高出12.8%
4.3%
自由现金流更多
OLPX
多$59.3M
$-26.7M
两年增速更快
ZLAB
近两年复合增速
3.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $105.1M | $127.1M |
| 净利润 | $-13.1M | — |
| 毛利率 | 68.0% | 51.0% |
| 营业利润率 | -4.3% | -54.6% |
| 净利率 | -12.5% | — |
| 营收同比 | 4.3% | 17.1% |
| 净利润同比 | -48.9% | — |
| 每股收益（稀释后） | $-0.02 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OLPXZLAB
| Q4 25 | $105.1M | $127.1M | ||
| Q3 25 | $114.6M | $115.4M | ||
| Q2 25 | $106.3M | $109.1M | ||
| Q1 25 | $97.0M | $105.7M | ||
| Q4 24 | $100.7M | $108.5M | ||
| Q3 24 | $119.1M | $101.8M | ||
| Q2 24 | $103.9M | $100.1M | ||
| Q1 24 | $98.9M | $87.1M |
净利润OLPXZLAB
| Q4 25 | $-13.1M | — | ||
| Q3 25 | $11.1M | $-36.0M | ||
| Q2 25 | $-7.7M | $-40.7M | ||
| Q1 25 | $465.0K | $-48.4M | ||
| Q4 24 | $-8.8M | — | ||
| Q3 24 | $14.8M | $-41.7M | ||
| Q2 24 | $5.8M | $-80.3M | ||
| Q1 24 | $7.7M | $-53.5M |
毛利率OLPXZLAB
| Q4 25 | 68.0% | 51.0% | ||
| Q3 25 | 69.1% | 59.5% | ||
| Q2 25 | 71.2% | 60.6% | ||
| Q1 25 | 69.5% | 63.6% | ||
| Q4 24 | 66.3% | 61.5% | ||
| Q3 24 | 68.6% | 64.1% | ||
| Q2 24 | 69.7% | 64.9% | ||
| Q1 24 | 72.1% | 61.4% |
营业利润率OLPXZLAB
| Q4 25 | -4.3% | -54.6% | ||
| Q3 25 | 3.7% | -42.3% | ||
| Q2 25 | -1.1% | -50.3% | ||
| Q1 25 | 8.7% | -53.3% | ||
| Q4 24 | 3.0% | -62.6% | ||
| Q3 24 | 23.5% | -66.6% | ||
| Q2 24 | 15.7% | -76.0% | ||
| Q1 24 | 19.8% | -80.7% |
净利率OLPXZLAB
| Q4 25 | -12.5% | — | ||
| Q3 25 | 9.7% | -31.2% | ||
| Q2 25 | -7.3% | -37.3% | ||
| Q1 25 | 0.5% | -45.8% | ||
| Q4 24 | -8.7% | — | ||
| Q3 24 | 12.4% | -40.9% | ||
| Q2 24 | 5.6% | -80.2% | ||
| Q1 24 | 7.8% | -61.4% |
每股收益（稀释后）OLPXZLAB
| Q4 25 | $-0.02 | $-0.05 | ||
| Q3 25 | $0.02 | $-0.03 | ||
| Q2 25 | $-0.01 | $-0.04 | ||
| Q1 25 | $0.00 | $-0.04 | ||
| Q4 24 | $-0.01 | $-0.09 | ||
| Q3 24 | $0.02 | $-0.04 | ||
| Q2 24 | $0.01 | $-0.08 | ||
| Q1 24 | $0.01 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $318.7M | $689.6M |
| 总债务越低越好 | $352.3M | — |
| 股东权益账面价值 | $879.4M | $715.5M |
| 总资产 | $1.5B | $1.2B |
| 负债/权益比越低杠杆越低 | 0.40× | — |
8季度趋势，按日历期对齐
现金及短期投资OLPXZLAB
| Q4 25 | $318.7M | $689.6M | ||
| Q3 25 | $286.4M | $717.2M | ||
| Q2 25 | $289.3M | $732.2M | ||
| Q1 25 | $580.9M | $757.3M | ||
| Q4 24 | $586.0M | $779.7M | ||
| Q3 24 | $538.8M | $616.1M | ||
| Q2 24 | $507.9M | $630.0M | ||
| Q1 24 | $507.5M | $650.8M |
总债务OLPXZLAB
| Q4 25 | $352.3M | — | ||
| Q3 25 | $352.1M | — | ||
| Q2 25 | $351.9M | — | ||
| Q1 25 | $649.1M | — | ||
| Q4 24 | $650.5M | — | ||
| Q3 24 | $651.8M | — | ||
| Q2 24 | $653.1M | — | ||
| Q1 24 | $654.4M | — |
股东权益OLPXZLAB
| Q4 25 | $879.4M | $715.5M | ||
| Q3 25 | $888.7M | $759.9M | ||
| Q2 25 | $874.2M | $791.7M | ||
| Q1 25 | $878.3M | $810.8M | ||
| Q4 24 | $874.4M | $840.9M | ||
| Q3 24 | $879.7M | $667.7M | ||
| Q2 24 | $863.3M | $704.2M | ||
| Q1 24 | $855.7M | $762.2M |
总资产OLPXZLAB
| Q4 25 | $1.5B | $1.2B | ||
| Q3 25 | $1.5B | $1.2B | ||
| Q2 25 | $1.5B | $1.2B | ||
| Q1 25 | $1.8B | $1.2B | ||
| Q4 24 | $1.8B | $1.2B | ||
| Q3 24 | $1.8B | $985.3M | ||
| Q2 24 | $1.8B | $987.4M | ||
| Q1 24 | $1.8B | $988.4M |
负债/权益比OLPXZLAB
| Q4 25 | 0.40× | — | ||
| Q3 25 | 0.40× | — | ||
| Q2 25 | 0.40× | — | ||
| Q1 25 | 0.74× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 0.74× | — | ||
| Q2 24 | 0.76× | — | ||
| Q1 24 | 0.76× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $32.7M | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | $32.6M | $-26.7M |
| 自由现金流率自由现金流/营收 | 31.0% | -21.0% |
| 资本支出强度资本支出/营收 | 0.1% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $58.3M | $-158.9M |
8季度趋势，按日历期对齐
经营现金流OLPXZLAB
| Q4 25 | $32.7M | $-26.0M | ||
| Q3 25 | $8.0M | $-32.0M | ||
| Q2 25 | $20.9M | $-31.0M | ||
| Q1 25 | $-2.9M | $-61.7M | ||
| Q4 24 | $49.7M | $-55.8M | ||
| Q3 24 | $33.5M | $-26.8M | ||
| Q2 24 | $16.2M | $-42.2M | ||
| Q1 24 | $43.7M | $-90.1M |
自由现金流OLPXZLAB
| Q4 25 | $32.6M | $-26.7M | ||
| Q3 25 | $7.9M | $-35.0M | ||
| Q2 25 | $20.8M | $-33.9M | ||
| Q1 25 | $-3.0M | $-63.2M | ||
| Q4 24 | $49.2M | $-58.4M | ||
| Q3 24 | $33.3M | $-28.2M | ||
| Q2 24 | $16.1M | $-42.9M | ||
| Q1 24 | $43.3M | $-91.1M |
自由现金流率OLPXZLAB
| Q4 25 | 31.0% | -21.0% | ||
| Q3 25 | 6.9% | -30.4% | ||
| Q2 25 | 19.6% | -31.1% | ||
| Q1 25 | -3.1% | -59.9% | ||
| Q4 24 | 48.9% | -53.8% | ||
| Q3 24 | 28.0% | -27.7% | ||
| Q2 24 | 15.5% | -42.9% | ||
| Q1 24 | 43.7% | -104.5% |
资本支出强度OLPXZLAB
| Q4 25 | 0.1% | 0.5% | ||
| Q3 25 | 0.1% | 2.6% | ||
| Q2 25 | 0.1% | 2.6% | ||
| Q1 25 | 0.0% | 1.5% | ||
| Q4 24 | 0.4% | 2.4% | ||
| Q3 24 | 0.1% | 1.3% | ||
| Q2 24 | 0.1% | 0.7% | ||
| Q1 24 | 0.5% | 1.1% |
现金转化率OLPXZLAB
| Q4 25 | — | — | ||
| Q3 25 | 0.72× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -6.27× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.26× | — | ||
| Q2 24 | 2.81× | — | ||
| Q1 24 | 5.64× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OLPX
| Sales Channel Directly To Consumer | $43.6M | 42% |
| Sales Channel Through Intermediary Professional | $36.8M | 35% |
| Sales Channel Through Intermediary Specialty Retail | $24.7M | 23% |
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
